Triple

T219129
Position Surface form Disambiguated ID Type / Status
Subject Department of Health and Social Care E4174 entity
Predicate oversees P46 FINISHED
Object NHS Blood and Transplant
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
E28059 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NHS Blood and Transplant | Statement: [Department of Health and Social Care, oversees, NHS Blood and Transplant]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: NHS Blood and Transplant
Context triple: [Department of Health and Social Care, oversees, NHS Blood and Transplant]
  • A. Cambridge University Hospitals NHS Foundation Trust
    Cambridge University Hospitals NHS Foundation Trust is a major NHS teaching and research hospital group in Cambridge, England, that provides specialist and general healthcare services in partnership with the University of Cambridge.
  • B. Committee for Advanced Therapies
    The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
  • C. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • D. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • E. Banting Research Foundation
    The Banting Research Foundation is a Canadian organization that funds early-career health and biomedical researchers, established to honor and continue the scientific legacy of insulin co-discoverer Sir Frederick Banting.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NHS Blood and Transplant
Triple: [Department of Health and Social Care, oversees, NHS Blood and Transplant]
Generated description
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: NHS Blood and Transplant
Target entity description: NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
  • A. Cambridge University Hospitals NHS Foundation Trust
    Cambridge University Hospitals NHS Foundation Trust is a major NHS teaching and research hospital group in Cambridge, England, that provides specialist and general healthcare services in partnership with the University of Cambridge.
  • B. Committee for Advanced Therapies
    The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
  • C. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • D. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • E. Banting Research Foundation
    The Banting Research Foundation is a Canadian organization that funds early-career health and biomedical researchers, established to honor and continue the scientific legacy of insulin co-discoverer Sir Frederick Banting.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2573508588190b522c2476d91acfe completed Feb. 28, 2026, 2:47 a.m.
NER Named-entity recognition batch_69a25c5199d8819096736c11077adec3 completed Feb. 28, 2026, 3:09 a.m.
NED1 Entity disambiguation (via context triple) batch_69a3476fe7a0819086ce5c028429b2c0 completed Feb. 28, 2026, 7:52 p.m.
NEDg Description generation batch_69a34a3ad4688190acdcca286cd8a19a completed Feb. 28, 2026, 8:04 p.m.
NED2 Entity disambiguation (via description) batch_69a34a97c5dc8190b0f3e4f3c342cfae completed Feb. 28, 2026, 8:05 p.m.
Created at: Feb. 28, 2026, 2:53 a.m.